Saturday - April 11, 2026

Synergy Source Labs LLC Launches CollaGenesis™, a Multi-Nutrient Collagen Nutrition System Featuring Marine and Vegan Synergy Blend Formulas

“Collagen alone is only one piece of the puzzle. The body depends on a coordinated network of nutrients to build and maintain collagen-rich tissues, and CollaGenesis™ was designed to deliver those elements together in one convenient formula,” said a spokesperson … Continue reading

Head and Neck Squamous Cell Carcinomas Market: Rapid Increment Driven by Innovation by 2034 – DelveInsight | M.D. Anderson Cancer Center, Sidney Kimmel, Centre hospitalier de, Dana-Farber Cancer

The Key Head and Neck Squamous Cell Carcinomas Companies in the market include – M.D. Anderson Cancer Center, Sidney Kimmel, Centre hospitalier de, Dana-Farber Cancer Institute, Inovio Pharmaceuticals, Hansoh BioMedical R&D Company, Gilead Sciences, Merck Sharp & Dohme LLC, Exelixis, … Continue reading

Night Vision Disturbances Pipeline 2026: MOA, ROA, FDA-Approved Drugs, and Clinical Trial Progress Assessment by DelveInsight | Opus Genetics, Viatris, Nevakar, Vyluma, Pfizer, Allergan, AbbVie

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Night Vision Disturbances pipeline constitutes key companies continuously working towards developing Night Vision Disturbances treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes … Continue reading

NK Cell Therapy Pipeline 2026: Therapies, MOA Insights, and Key Clinical Trial Updates by DelveInsight | Amgen, ImmunityBio, Dragonfly Therapeutics, Glycostem Therapeutics, Athenex, Artiva Biotherap

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, NK Cell Therapy pipeline constitutes 140+ key companies continuously working towards developing 160+ Nk Cell Therapy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and … Continue reading